BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 32432651)

  • 1. Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.
    Bainey KR; Engstrøm T; Smits PC; Gershlick AH; James SK; Storey RF; Wood DA; Mehran R; Cairns JA; Mehta SR
    JAMA Cardiol; 2020 Aug; 5(8):881-888. PubMed ID: 32432651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.
    Wood DA; Cairns JA; Wang J; Mehran R; Storey RF; Nguyen H; Meeks B; Kunadian V; Tanguay JF; Kim HH; Cheema A; Dehghani P; Natarajan MK; Jolly SS; Amerena J; Keltai M; James S; Hlinomaz O; Niemela K; AlHabib K; Lewis BS; Nguyen M; Sarma J; Dzavik V; Della Siega A; Mehta SR;
    J Am Coll Cardiol; 2019 Dec; 74(22):2713-2723. PubMed ID: 31779786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial.
    Denormandie P; Simon T; Cayla G; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; le Breton H; Valy Y; Schiele F; Cuisset T; Vanzetto G; Levesque S; Goube P; Nallet O; Angoulvant D; Roubille F; Charles Nelson A; Chatellier G; Danchin N; Puymirat E
    Circ Cardiovasc Interv; 2021 Nov; 14(11):e011314. PubMed ID: 34420366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial.
    Puymirat E; Simon T; de Bruyne B; Montalescot G; Steg G; Cayla G; Durand-Zaleski I; Blanchard D; Danchin N; Chatellier G;
    Am Heart J; 2020 Apr; 222():1-7. PubMed ID: 32000067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease.
    Sheth T; Pinilla-Echeverri N; Moreno R; Wang J; Wood DA; Storey RF; Mehran R; Bainey KR; Bossard M; Bangalore S; Schwalm JD; Velianou JL; Valettas N; Sibbald M; Rodés-Cabau J; Ducas J; Cohen EA; Bagai A; Rinfret S; Newby DE; Feldman L; Laster SB; Lang IM; Mills JD; Cairns JA; Mehta SR
    J Am Coll Cardiol; 2020 Sep; 76(11):1277-1286. PubMed ID: 32912441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.
    Mehta SR; Wang J; Wood DA; Spertus JA; Cohen DJ; Mehran R; Storey RF; Steg PG; Pinilla-Echeverri N; Sheth T; Bainey KR; Bangalore S; Cantor WJ; Faxon DP; Feldman LJ; Jolly SS; Kunadian V; Lavi S; Lopez-Sendon J; Madan M; Moreno R; Rao SV; Rodés-Cabau J; Stankovic G; Bangdiwala SI; Cairns JA;
    JAMA Cardiol; 2022 Nov; 7(11):1091-1099. PubMed ID: 36129696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
    Bainey KR; Mehta SR; Lai T; Welsh RC
    Am Heart J; 2014 Jan; 167(1):1-14.e2. PubMed ID: 24332136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiography versus FFR guided complete revascularization versus culprit-only revascularization for patients presenting with STEMI: Network meta-analysis.
    Okuya Y; Gohil K; Moussa ID
    Catheter Cardiovasc Interv; 2022 Sep; 100(3):340-350. PubMed ID: 35789058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.
    Puymirat E; Cayla G; Simon T; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; Gallet R; Khalife K; Morelle JF; Motreff P; Lemesle G; Dillinger JG; Lhermusier T; Silvain J; Roule V; Labèque JN; Rangé G; Ducrocq G; Cottin Y; Blanchard D; Charles Nelson A; De Bruyne B; Chatellier G; Danchin N;
    N Engl J Med; 2021 Jul; 385(4):297-308. PubMed ID: 33999545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culprit-lesion only versus complete multivessel percutaneous intervention in ST-elevation myocardial infarction: A systematic review and meta-analysis of randomized trials.
    Villablanca PA; Briceno DF; Massera D; Hlinomaz O; Lombardo M; Bortnick AE; Menegus MA; Pyo RT; Garcia MJ; Mookadam F; Ramakrishna H; Wiley J; Faggioni M; Dangas GD
    Int J Cardiol; 2016 Oct; 220():251-9. PubMed ID: 27390938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis Comparing Fractional Flow Reserve and Angiography-Guided Complete Revascularization of Nonculprit Artery for ST-Elevation Myocardial Infarction.
    Omar A; Senguttuvan NB; Ueyama H; Kuno T; Beerkens F; Rahim M; Elmariah H; Takagi H; Abdulkader RS; Yallanki HP; Pelliccia F; Mylavarapu DP; Claessen B; Pasceri V; Dangas G
    Am J Cardiol; 2022 Nov; 183():8-15. PubMed ID: 36115726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis.
    Archilletti F; Ricci F; Pelliccia F; Dangas G; Giuliani L; Radico F; Perfetti M; Rossi S; Gallina S; Maddestra N; Khanji MY; Zimarino M
    Int J Cardiol; 2023 Jan; 370():122-128. PubMed ID: 36328114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FFR- Versus Angiography-Guided Revascularization for Nonculprit Stenosis in STEMI and Multivessel Disease: A Network Meta-Analysis.
    Elbadawi A; Dang AT; Hamed M; Eid M; Prakash Hiriyur Prakash M; Saleh M; Gad M; Mamas MA; Rahman F; Elgendy IY
    JACC Cardiovasc Interv; 2022 Mar; 15(6):656-666. PubMed ID: 35331458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
    Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA;
    Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Fractional Flow Reserve-Guided Treatment for Acute Myocardial Infarction and Multivessel Disease: A Prespecified Analysis of the FRAME-AMI Randomized Clinical Trial.
    Hong D; Lee SH; Lee J; Lee H; Shin D; Kim HK; Park KH; Choo EH; Kim CJ; Kim MC; Hong YJ; Jeong MH; Ahn SG; Doh JH; Lee SY; Don Park S; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Guallar E; Cho J; Hahn JY; Kang D; Lee JM;
    JAMA Netw Open; 2024 Jan; 7(1):e2352427. PubMed ID: 38270954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.